US Stock MarketDetailed Quotes

ALRN Aileron Therapeutics

Watchlist

4.0000
-0.1200-2.91%

Close Nov 1 16:00 ET

86.66MMarket Cap-1290P/E (TTM)

Aileron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

334.57%9.04M

80.62%7.21M

-44.49%15.35M

55.26%7.3M

-69.50%1.98M

-74.13%2.08M

-52.63%3.99M

3.92%27.65M

-31.00%4.7M

-4.55%6.48M

Selling and administrative expenses

179.87%5.3M

71.73%3.74M

17.32%11.36M

131.64%5.33M

-12.84%1.96M

-27.42%1.89M

-13.81%2.18M

0.86%9.68M

2.04%2.3M

-10.74%2.24M

-General and administrative expense

179.87%5.3M

71.73%3.74M

17.32%11.36M

131.64%5.33M

-12.84%1.96M

-27.42%1.89M

-13.81%2.18M

0.86%9.68M

2.04%2.3M

-10.74%2.24M

Research and development costs

1,900.53%3.74M

91.33%3.46M

-77.79%3.99M

-17.90%1.97M

-99.48%22K

-96.56%187K

-69.29%1.81M

5.64%17.97M

-47.34%2.4M

-0.91%4.24M

Operating profit

-334.57%-9.04M

-80.62%-7.21M

44.49%-15.35M

-55.26%-7.3M

69.50%-1.98M

74.13%-2.08M

52.63%-3.99M

-3.92%-27.65M

31.00%-4.7M

4.55%-6.48M

Net non-operating interest income expense

400K

78K

40.91%155K

423.81%110K

Non-operating interest income

----

--400K

--78K

40.91%155K

----

423.81%110K

Other net income (expense)

-66.89%97K

111.65%92K

-328.93%-728K

-117.56%-59K

-225.00%-5K

293K

-3,490.91%-790K

-27.89%318K

373.24%336K

-93.94%4K

Gain on sale of security

----

--200K

----

Special income (charges)

--0

---928K

--12K

---6K

--88K

---1.02M

--0

-Less：Restructuring and merger&acquisition

--0

--928K

---12K

--6K

---88K

--1.02M

--0

Other non- operating income (expenses)

-52.68%97K

-60.34%92K

----

-75.00%1K

--205K

1,154.55%232K

-27.89%318K

373.24%336K

-93.94%4K

Income before tax

-400.39%-8.94M

-48.84%-7.11M

42.64%-15.68M

-60.17%-7.28M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

5.01%-6.37M

Income tax

Net income

-400.39%-8.94M

-48.84%-7.11M

42.64%-15.68M

-60.17%-7.28M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

5.01%-6.37M

Net income continuous Operations

-400.39%-8.94M

-48.84%-7.11M

42.64%-15.68M

-60.17%-7.28M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

5.01%-6.37M

Minority interest income

Net income attributable to the parent company

-400.39%-8.94M

-48.84%-7.11M

42.43%-15.73M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

5.01%-6.37M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-400.39%-8.94M

-48.84%-7.11M

42.43%-15.73M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

-4.45%-27.33M

33.12%-4.55M

5.01%-6.37M

Basic earnings per share

-15.38%-0.45

18.10%-0.86

43.19%-3.42

-57.00%-1.57

71.43%-0.4

77.84%-0.39

43.55%-1.05

-2.21%-6.02

32.89%-1

0.00%-1.4

Diluted earnings per share

-15.38%-0.45

18.10%-0.86

43.19%-3.42

-57.00%-1.57

71.43%-0.4

77.84%-0.39

43.55%-1.05

-2.21%-6.02

32.89%-1

0.00%-1.4

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	334.57%9.04M	80.62%7.21M	-44.49%15.35M	55.26%7.3M	-69.50%1.98M	-74.13%2.08M	-52.63%3.99M	3.92%27.65M	-31.00%4.7M	-4.55%6.48M
Selling and administrative expenses	179.87%5.3M	71.73%3.74M	17.32%11.36M	131.64%5.33M	-12.84%1.96M	-27.42%1.89M	-13.81%2.18M	0.86%9.68M	2.04%2.3M	-10.74%2.24M
-General and administrative expense	179.87%5.3M	71.73%3.74M	17.32%11.36M	131.64%5.33M	-12.84%1.96M	-27.42%1.89M	-13.81%2.18M	0.86%9.68M	2.04%2.3M	-10.74%2.24M
Research and development costs	1,900.53%3.74M	91.33%3.46M	-77.79%3.99M	-17.90%1.97M	-99.48%22K	-96.56%187K	-69.29%1.81M	5.64%17.97M	-47.34%2.4M	-0.91%4.24M
Operating profit	-334.57%-9.04M	-80.62%-7.21M	44.49%-15.35M	-55.26%-7.3M	69.50%-1.98M	74.13%-2.08M	52.63%-3.99M	-3.92%-27.65M	31.00%-4.7M	4.55%-6.48M
Net non-operating interest income expense			400K	78K	40.91%155K					423.81%110K
Non-operating interest income	----	----	--400K	--78K	40.91%155K	----	----	----	----	423.81%110K
Other net income (expense)	-66.89%97K	111.65%92K	-328.93%-728K	-117.56%-59K	-225.00%-5K	293K	-3,490.91%-790K	-27.89%318K	373.24%336K	-93.94%4K
Gain on sale of security	----	----	--200K	----	----	----	----	----	----	----
Special income (charges)	--0	--0	---928K	--12K	---6K	--88K	---1.02M	--0	--0	--0
-Less：Restructuring and merger&acquisition	--0	--0	--928K	---12K	--6K	---88K	--1.02M	--0	--0	--0
Other non- operating income (expenses)	-52.68%97K	-60.34%92K	----	----	-75.00%1K	--205K	1,154.55%232K	-27.89%318K	373.24%336K	-93.94%4K
Income before tax	-400.39%-8.94M	-48.84%-7.11M	42.64%-15.68M	-60.17%-7.28M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M	5.01%-6.37M
Income tax
Net income	-400.39%-8.94M	-48.84%-7.11M	42.64%-15.68M	-60.17%-7.28M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M	5.01%-6.37M
Net income continuous Operations	-400.39%-8.94M	-48.84%-7.11M	42.64%-15.68M	-60.17%-7.28M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M	5.01%-6.37M
Minority interest income
Net income attributable to the parent company	-400.39%-8.94M	-48.84%-7.11M	42.43%-15.73M	-61.40%-7.34M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M	5.01%-6.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-400.39%-8.94M	-48.84%-7.11M	42.43%-15.73M	-61.40%-7.34M	71.31%-1.83M	77.64%-1.79M	43.26%-4.78M	-4.45%-27.33M	33.12%-4.55M	5.01%-6.37M
Basic earnings per share	-15.38%-0.45	18.10%-0.86	43.19%-3.42	-57.00%-1.57	71.43%-0.4	77.84%-0.39	43.55%-1.05	-2.21%-6.02	32.89%-1	0.00%-1.4
Diluted earnings per share	-15.38%-0.45	18.10%-0.86	43.19%-3.42	-57.00%-1.57	71.43%-0.4	77.84%-0.39	43.55%-1.05	-2.21%-6.02	32.89%-1	0.00%-1.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data